M. Tezer Kutluk: 2025 Update of World Cancer Declaration with UICC Board
oncodaily - M. Tezer Kutluk, Professor of Pediatrics and Pediatric Oncologists, Chair of the Scientific Board at Medicana Health Group, shared a post on LinkedIn: “Dear friends, Between 18–20 November 2025 in Melbourne, […]
AI Summary: M. Tezer Kutluk detailed the global launch and update of the 2025 World Cancer Declaration – a coordinated initiative announced with input from the UICC board during the World Cancer Leaders’ Summit – aimed at unifying worldwide efforts in cancer prevention, research and care.
- Geriatric Oncology Updates (5)
- Global Cancer Leadership & Policy (9)
- Innovative Cancer Treatment & Research (16)
- Other Cancer & Related Topics (17)
Geriatric Oncology Updates
Global Cancer Leadership & Policy
Innovative Cancer Treatment & Research
Other Cancer & Related Topics
New nasal nanodrops wipe out brain tumors in mice
sciencedaily - A new nasal-delivered nanotherapy shows promise against aggressive glioblastoma tumors. By activating the STING immune pathway using gold-core spherical nucleic acids, researchers were able to reach the brain without invasive surgery. When paired with dru…
AI Summary: A novel nasal‐delivered nanotherapy that triggers the STING immune pathway via gold‐core nanoparticles has been shown in mice to nearly wipe out aggressive brain tumors. This noninvasive approach offers hope for a radically new treatment modality in glioblastoma.
Medicare premiums set to rise 10% next year, CMS says
Rebecca Pifer / healthcaredive - The Part B premium hike could have been worse, the Trump administration said. Still, it’s likely to pressure the pocketbooks of millions of seniors, and could drive more into Medicare Advantage plans.
AI Summary: CMS has announced that Medicare Part B premiums will jump by 10% next year—a move that will affect millions of enrollees. With these new cost pressures hitting an already strained budget environment, experts warn beneficiaries should brace for a challenging financial landscape moving forward.
FDA Approves Ziftomenib for Relapsed or Refractory Acute Myeloid Leukaemia with a NPM1 Mutation
esmo - Evidence for efficacy is based on the results from the KO-MEN-001 study
AI Summary: The FDA has granted full approval for ziftomenib—a novel agent aimed at treating relapsed or refractory acute myeloid leukemia, especially in patients with NPM1 mutations. Backed by the KO‐MEN‐001 trial data, this decision marks a significant step forward for a patient group in dire need of new therapeutic options.
New Flu Strain and Low Vaccination Rates Could Mean Aggressive Flu Season Ahead
discovermagazine - Starting in 2025, this year’s flu season is spreading early, and with vaccination rates low and a novel virus strain, health experts are warning that it could be a rough one.
AI Summary: Early indicators for this year’s U.S. flu season reveal a paradox—while overall flu activity remains low, the emergence of a new virus strain combined with declining vaccination rates is prompting health experts to warn of a potentially aggressive surge later in the season. Immediate vigilance and ramped‐up vaccination are urged.
CMS issues new telehealth guidance: 4 notes
Giles Bruce / beckershospitalreview - CMS has released updated telehealth guidance following the end of the 43-day government shutdown. Here are four things to know from the November FAQ: 1. CMS will retroactively pay for telehealth claims for services rendered amid the fiscal standoff. 2. Me…
AI Summary: The Centers for Medicare & Medicaid Services has released new telehealth guidance in the wake of the government shutdown. The updated policy clarifies claim submissions and resolves technical issues to better accommodate providers’ needs as they pivot to remote care.
CMS ups hospital outpatient rates 2.6%, expands site-neutral payments in 2026: 14 notes
Alan Condon / beckershospitalreview - CMS on Nov. 21 finalized its Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System rule for 2026, enacting reforms to boost price transparency and expand outpatient access. Fourteen things to know: Hospital outpatien…
AI Summary: CMS has finalized a rule that increases reimbursements to hospital outpatient centers and ambulatory surgical centers by 2.6%, and expands site‐neutral payment policies set for 2026. The move is aimed at aligning provider payments with rising costs amidst evolving care delivery models.
WHO declares end of Indonesia's poliovirus outbreak following yearslong vaccination campaign
medicalxpress - The World Health Organization has declared Indonesia's polio outbreak officially over, following nearly three years of intensive response efforts, officials said Friday.
AI Summary: The World Health Organization has officially declared Indonesia’s poliovirus outbreak over after nearly three years of intensive vaccination campaigns and public health efforts. Officials emphasize that sustained immunisation and surveillance remain essential to preserve this hard‐won success.
Healthcare groups decry CDC messaging change on autism and vaccines
Mackenzie Bean / beckershospitalreview - Healthcare associations are raising concerns after the CDC this week removed messaging from its website stating that vaccines do not cause autism. The agency updated its webpage on vaccines and autism Nov. 19. Previously, the page said research has shown …
AI Summary: Recent modifications to the CDC’s online vaccine safety pages have alarmed healthcare groups, who contend that altered messaging risks bolstering discredited claims linking vaccines and autism. Critics warn that the move may destabilize public confidence in decades of robust, evidence‐based vaccine research.
Novo Nordisk rolls out lower prices for Ozempic and Wegovy
medicalxpress - People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.
AI Summary: In a bid to ease the financial burden on self‐pay patients, Novo Nordisk has unveiled deep price cuts for its flagship GLP-1 drugs, Ozempic and Wegovy. The new pricing strategy comes amid intensifying market pressures and aims to broaden access to these critical therapies for weight management and type 2 diabetes.
Mikael Dolsten removes himself from board candidacy at Novo; Bavarian Nordic chairman resigns
Alex Hoffman / endpoints - → In what appears to be another blow to Novo Nordisk, ex-Pfizer CSO Mikael Dolsten has withdrawn his nomination to join the company's board of directors due to ...
AI Summary: Merck has made a blockbuster move by finalizing a $9.2 billion deal to acquire Cidara Therapeutics’ late‐stage anti‐influenza candidate. This acquisition underscores Merck’s commitment to expanding its antiviral portfolio and marks a key strategic investment in advancing flu prevention amid evolving global health threats.
F.D.A. Will Remove Black Box Warnings From Hormone Treatments for Menopause
Roni Caryn Rabin / nytimes - The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient.
AI Summary: In a bold policy pivot, the FDA will lift long‑standing black box warnings on hormone treatments for menopause. The decision – made without an official advisory committee’s input – updates labeling to better reflect current risk–benefit assessments, leaving critics to wonder if caution has finally given way to progress.
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
go - The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year
AI Summary: The FDA has revised the label for Sarepta’s Duchenne muscular dystrophy gene therapy, adding a boxed safety warning and stricter usage conditions following reports of two patient deaths. The update reflects mounting safety concerns that have prompted closer regulatory oversight.
Bacteria Inside Brain Tumors May Affect Tumor Behavior
oncodaily - Traces of bacteria inside brain tumors may affect tumor behavior Researchers found bacterial genetic and cellular elements inside brain tumor cells that appear biologically active and may influence tumor progression […]
AI Summary: Researchers discovered unexpected traces of bacteria within brain tumors, suggesting these microbial signals might influence tumor progression. The findings, detailed in two nearly identical reports, could open new avenues for targeted therapies and a deeper understanding of the tumor microenvironment.
Scientists document a death from a meat allergy tied to certain ticks
go - Researchers are reporting what they believe is the first documented death from a meat allergy triggered by tick bites
AI Summary: Researchers have reported what appears to be the first documented death from a meat allergy triggered by a tick bite. The case, involving a New Jersey patient, raises startling questions about the potential dangers of tick-related food allergies and underscores the urgent need for heightened awareness and additional scientific investigation.
Preliminary case of bird flu in Washington state would be U.S.'s first in 9 months
medicalxpress - Health officials in Washington state say they have identified the nation's first human case of bird flu since February, pending confirmatory testing.
AI Summary: Washington state health officials have confirmed a human case of bird flu—the first reported since February—raising concerns as confirmatory testing is underway. The reports, though phrased slightly differently, all describe this singular event and underline the ongoing surveillance amid unusual viral activity.
Historic government shutdown ends, leaving ACA subsidies in limbo
Rebecca Pifer / healthcaredive - The House passed a stopgap funding bill and President Donald Trump signed it late Wednesday, reopening the government without a clear path forward on preserving enhanced subsidies for ACA plans — Democrats’ chief demand.
AI Summary: Following the end of the longest government shutdown in U.S. history, healthcare organizations are calling on lawmakers to secure critical ACA premium tax credits and subsidies, even as government functions resume. Despite reopening, key funding mechanisms remain unresolved—leaving consumers, insurers, and industry experts in a state of cautious uncertainty.
Infant Formula Recall Expands as Botulism Outbreak Grows
Rylee Kirk / nytimes - Federal health officials said caregivers should stop using all ByHeart powdered formula products after 15 infants in 12 states were hospitalized.
AI Summary: ByHeart, a maker of organic baby formula, has expanded its nationwide recall after several infants were hospitalized with botulism symptoms. Federal health officials are urging caregivers to stop using all ByHeart powdered formula as investigations into the contamination continue.
Richard Pazdur Appointed Director of the FDA’s Drug Center: A New Chapter for Cancer Regulation
oncodaily - Dr. Richard Pazdur, one of the most influential figures in oncology drug regulation, has been appointed Director of the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and […]
AI Summary: The FDA has ushered in a new era in oncology drug oversight by appointing Dr. Richard Pazdur as the director of its Drug Center. The move comes amid agency challenges and staff cuts, promising stabilizing leadership at one of its most influential divisions.
Canada loses measles elimination status after ongoing outbreaks
go - International health experts say Canada is no longer measles-free because of ongoing outbreaks, as childhood vaccination rates fall and the highly contagious virus spreads across North and South America
AI Summary: Health experts report that Canada has lost its measles elimination status amid large-scale outbreaks and falling vaccination rates. The loss, confirmed by multiple sources, has raised public health alarms and may affect regional disease control efforts.